Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system

References

• Ayal G, Andelman D, Cohen Y. 2009. Analytical model for ArF photoresist shrinkage under scanning electron microscopy inspection. J Vacuum Sci Technol B: Microelectron Nanometer Struct Process Meas Phenomena. 27:1976–1983.
   Web of Science ®Google Scholar
• Bahari Javan N, Montazeri H, Rezaie Shirmard L, Jafari Omid N, Barbari GR, Amini M, Ghahremani MH, Rafiee-Tehrani M, Abedin Dorkoosh F. 2017. Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide. Eur J Pharm Sci. 101:167–181.
   PubMed Web of Science ®Google Scholar
• Bahari Javan N, Rezaie Shirmard L, Jafary Omid N, Akbari Javar H, Rafiee Tehrani M, Abedin Dorkoosh F. 2016. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. J Microencapsul. 15:1–5.
   Google Scholar
• Baş D, Boyacı İH. 2007. Modeling and optimization I: usability of response surface methodology. J Food Eng. 78:836–845.
   Web of Science ®Google Scholar
• Behera AK, Shah S, Barik BB. 2013. Development and enhancement of entrapment efficiency of isoniazid loaded poly-ɛ-caprolactone nanoparticle. Scholars Res Library. 5:43–50.
   Google Scholar
• Behl CR, Pimplaskar HK, Sileno AP, Xia WJ, Gries WJ, Demeireles JC, Romeo VD. 1998. Optimization of systemic nasal drug delivery with pharmaceutical excipients. Adv Drug Deliv Rev. 29:117–133.
   PubMed Web of Science ®Google Scholar
• Berberoğlu M. 2009. Precocious Puberty and Normal Variant Puberty: definition, etiology, diagnosis and current management – review. J Clin Res Pediatr Endocrinol. 1:164–174.
   PubMedGoogle Scholar
• Bootz A, Vogel V, Schubert D, Kreuter J. 2004. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly (butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm. 57:369–375.
   PubMed Web of Science ®Google Scholar
• Christoper GP, Raghavan CV, Siddharth K, Kumar MS, Prasad RH. 2014. Formulation and optimization of coated PLGA–Zidovudine nanoparticles using factorial design and in vitro in vivo evaluations to determine brain targeting efficiency. Saudi Pharm J. 22:133–140.
   PubMed Web of Science ®Google Scholar
• Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM. 2011. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopharm. 77:26–35.
   PubMed Web of Science ®Google Scholar
• Dangre PV, Kattekar KR, Shirolkar SV. 2013. Development and evaluation of in situ gelling otic formulation of chloramphenicol using poloxamer 407. Indo Am J Pharm Res. 3:8001–8007.
   Google Scholar
• Derakhshandeh K, Fashi M, Seifoleslami S. 2010. Thermosensitive Pluronic® hydrogel: prolonged injectable formulation for drug abuse. Drug Des Dev Ther. 4:255–262.
   PubMed Web of Science ®Google Scholar
• Dondeti P, Zia H, Needham TE. 1996. Bioadhesive and formulation parameters affecting nasal absorption. Int J Pharm. 127:115–133.
   Web of Science ®Google Scholar
• Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. 2006. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 23:2709–2728.
   PubMed Web of Science ®Google Scholar
• Elwerfalli AM, Al-Kinani A, Alany RG, ElShaer A. 2015. Nano-engineering chitosan particles to sustain the release of promethazine from orodispersables. Carbohydr Polym. 131:447–461.
   PubMed Web of Science ®Google Scholar
• Escobar-Chávez JJ, López-Cervantes M, Naik A, Kalia Y, Quintanar-Guerrero D, Ganem-Quintanar A. 2006. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci. 9:339–358.
   PubMed Web of Science ®Google Scholar
• Fiedot M, Rac O, Suchorska-Woźniak P, Karbownik I, Teterycz H. 2015. Polymer–surfactant interactions and their influence on zinc oxide nanoparticles morphology. Manufact Nanostruct. 4:108–128.
   Google Scholar
• Fukada E, Ando Y. 1986. Piezoelectric properties of poly b-hydroxybutyrate and copolymers of b-hydroxybutyrate and b-hydroxyvalerate. Int J Biol Macromol. 8:361–366.
   Web of Science ®Google Scholar
• Ghasemian E, Vatanara A, Najafabadi AR, Rouini MR, Gilani K, Darabi M. 2013. Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design. DARU J Pharm Sci. 21:1.
   Web of Science ®Google Scholar
• Gu B, Burgess DJ. 2015. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach. Int J Pharm. 495:393–403.
   PubMed Web of Science ®Google Scholar
• Guhagarkar S, Malshe V, Devarajan P. 2009. Nanoparticles of polyethylene sebacate: a new biodegradable polymer. AAPS PharmSciTech. 10:935–942.
   PubMed Web of Science ®Google Scholar
• Hayden C. 2008. GnRH analogues: applications in assisted reproductive techniques. Eur J Endocrinol. 159:17–25.
   PubMed Web of Science ®Google Scholar
• Henzl MR, Kwei L. 1990. Efficacy and safety of nafarelin in the treatment of endometriosis. Am J Obstet Gynecol. 162:570–574.
   PubMed Web of Science ®Google Scholar
• Islam MI, Hossain MK, Ahmed T, Bhusal P, Rana MS, Khan TA. 2013. The effect of hydrophilic and hydrophobic polymers on release profiles of diclofenac sodium from matrix tablets. Arch Pharm Pract. 4:120.
   Google Scholar
• Jayamanti P, Yasmin S, Mohd A. 2014. Poly(lactide-co-glycolide) nanoparticles for an extended delivery of bevacizumab to retina: formulation and in vitro characterization. Adv Sci Lett. 20:1588–1593.
   Google Scholar
• Kenley RA, Hamme KJ, Lee MO, Tom J. 1987. Silica-based size exclusion chromatography to characterize the decapeptide nafarelin in a controlled-release pharmaceutical formulation. Anal Chem. 59:2050–2054.
   PubMed Web of Science ®Google Scholar
• Khoee S, Sattari A, Atyabi F. 2012. Physico-chemical properties investigation of cisplatin loaded polybutyladipate (PBA) nanoparticles prepared by w/o/w. Mater Sci Eng C. 32:1078–1086.
   Web of Science ®Google Scholar
• Koosha F, Muller R, Davis S. 1989. Polyhydroxybutyrate as a drug carrier. Crit Rev Ther Drug Carrier Syst. 6:117–130.
   PubMed Web of Science ®Google Scholar
• Kose G, Korkusuz F, Ozkul A, Soysal Y, Ozdemir T, Yildiz C, Hasirci V. 2005. Tissue engineered cartilage on collagen and PHBV matrices. Biomaterials. 26:5187–5197.
   PubMed Web of Science ®Google Scholar
• Kudo T, Bae JB, Dammel RR, Kim WK, McKenzie D, Rahman MD, Padmanaban M, Ng W, Houlihan FM. 2001. CD changes of 193-nm resists during SEM measurement. In Proc SPIE. 4345:179.
   Google Scholar
• Kumari A, Yadav SK, Yadav SC. 2010. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 75:1–18.
   PubMed Web of Science ®Google Scholar
• Lakowicz JR. 2006. Principles of fluorescence spectroscopy. 3rd ed. New York: Springer.
   Google Scholar
• Lim JI, Kim JH. 2015. Enhanced biocompatibility and adhesive properties of modified allyl 2-cyanoacrylate-based elastic bio-glues. Colloids Surf B Biointerfaces. 133:19–23.
   PubMed Web of Science ®Google Scholar
• Lin TH, LePage ME, Henzl M, Kirkland JL. 1986. Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty. J Pediatr. 109:954–958.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhu YY, Wei G, Lu WY. 2009. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: improved in vitro and in vivo sustained-release properties. Eur J Pharm Sci. 37(3):306–312.
   Web of Science ®Google Scholar
• Ludwig A. 2005. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 57:1595–1639.
   PubMed Web of Science ®Google Scholar
• Mahboubian A, Hashemein S, Moghadam S, Atyabi F, Dinarvand R. 2010. Preparation and in-vitro evaluation of controlled release PLGA microparticles containing triptoreline. Iran J Pharm Res. 9:369–378.
   PubMed Web of Science ®Google Scholar
• Marquette S, Peerboom C, Yates A, Denis L, Goole J, Amighi K. 2014. Encapsulation of immunoglobulin G by solid-in-oil-in-water: effect of process parameters on microsphere properties. Eur J Pharm Biopharm. 86:393–403.
   PubMed Web of Science ®Google Scholar
• Martin MC, Givens CR, Schriock ED, Glass RH, Dandekar PV. 1994. The choice of a gonadotropin-releasing hormone analog influences outcome of in vitro fertilization treatment. Am J Obstet Gynecol. 170:1629–1634.
   PubMed Web of Science ®Google Scholar
• Mayol L, Quaglia F, Borzacchiello A, Ambrosio L, La Rotonda MI. 2008. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. Eur J Pharm Biopharm. 70:199–206.
   PubMed Web of Science ®Google Scholar
• Mendes JB, Riekes MK, de Oliveira VM, Michel MD, Stulzer HK, Khalil NM, Zawadzki SF, Mainardes RM, Farago PV. 2012. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. Sci World J. 2012:1–13.
   Web of Science ®Google Scholar
• Miller BS, Shukla AR. 2010. Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists. Clin Ther. 32:1749–1751.
   PubMed Web of Science ®Google Scholar
• Moebus K, Siepmann J, Bodmeier R. 2009. Alginate-poloxamer microparticles for controlled drug delivery to mucosal tissue. Eur J Pharm Biopharm. 72:42–53.
   PubMed Web of Science ®Google Scholar
• Mohanraj V, Chen Y, Suresh B. 2006. Chitosan-based nanoparticles for delivery of proteins and peptides. Indian J Pharm Educ Res. 40:106–115.
   Google Scholar
• Mohanraj V, Chen Y. 2007. Nanoparticles-a review. Trop J Pharm Res. 5:561–573.
   Google Scholar
• Nabi-Meibodi M, Navidi B, Navidi N, Vatanara A, Rouini MR, Ramezani V. 2013. Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug. J Drug Deliv Sci Technol. 23:225–230.
   Web of Science ®Google Scholar
• Nicoli S, Santi P, Couvreur P, Couarraze G, Colombo P, Fattal E. 2001. Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. Int J Pharm. 214:31–35.
   PubMed Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. 1994. In vitro drug release behavior of d,l-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J Pharm Sci. 83:727–732.
   PubMed Web of Science ®Google Scholar
• Noori Koopaei M, Khoshayand MR, Mostafavi SH, Amini M, Khorramizadeh MR, Jeddi Tehrani M, Atyabi F, Dinarvand R. 2014. Docetaxel loaded PEG-PLGA nanoparticles: optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect. Iran J Pharm Res. 13:819–833.
   PubMed Web of Science ®Google Scholar
• Öchsner A, Shokuhfar A. 2013. New frontiers of nanoparticles and nanocomposite materials. Berlin, Heidelberg: Springer-Verlag.
   Google Scholar
• Okada H, Doken Y, Ogawa Y, Toguchi H. 1994. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm Res. 11:1143–1147.
   PubMed Web of Science ®Google Scholar
• Pain L, Monti N, Martin N, Tirard W, Gandolfi A, Bollin M. 2000. Study of 193nm resist behavior under SEM inspection: how to reduce linewidth shrinkage effect. In Proc Interface. 2000:233–248.
   Google Scholar
• Pal SL, Jana U, Manna P, Mohanta G, Manavalan R. 2011. Nanoparticle: an overview of preparation and characterization. J Appl Pharm Sci. 1:228–234.
   Google Scholar
• Partsch CJ, Sippell WG. 2002. Treatment of central precocious puberty. Best Pract Res Clin Endocrinol Metab. 16:165–189.
   PubMed Web of Science ®Google Scholar
• Pouton C, Akhtar S. 1996. Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Adv Drug Deliv Rev. 18:133–162.
   Web of Science ®Google Scholar
• Pujara CP, Shao Z, Duncan MR, Mitra AK. 1995. Effects of formulation variables on nasal epithelial cell integrity: biochemical evaluations. Int J Pharm. 114:197–203.
   Web of Science ®Google Scholar
• Ramyadevi D, Rajan KS, Vedhahari BN, Ruckmani K, Subramanian N. 2016. Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes. Colloids Surf B Biointerfaces. 146:260–270.
   PubMed Web of Science ®Google Scholar
• Rezaie Shirmard L, Bahari Javan N, Khoshayand MR, Kebriaee-zadeh A, Dinarvand R, Dorkoosh FA. 2015. Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation. Pharmaceut Develop Technol. doi:10.3109/10837450.1108982.
   PubMed Web of Science ®Google Scholar
• Ritthidej GC. 2011. Peptide and protein delivery. San Diego (CA): Academic Press; p. 47–68.
   Google Scholar
• Saadat E, Abdollahi A, Dorkoosh FA. 2015. Fabrication and characterization of risperidone implants as an extended antipsychotic delivery system, exploring the role of excipients. J Pharm Innov. 10:118–129.
   Web of Science ®Google Scholar
• Simões SM, Veiga F, Torres-Labandeira JJ, Ribeiro AC, Sandez-Macho MI, Concheiro A, Alvarez-Lorenzo C. 2012. Syringeable Pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin. Eur J Pharm Biopharm. 80:103–112.
   PubMed Web of Science ®Google Scholar
• Srividya B, Cardoza RM, Amin PD. 2001. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release. 73:205–211.
   PubMed Web of Science ®Google Scholar
• Sudhakav M, Kancharlo R, Rao VU. 2013. A review on sustained release injectable depot drug delivery systems. J Adv Pharm Sci. 4:142–158.
   Google Scholar
• Tan ML, Choong PF, Dass CR. 2010. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides. 31:184–193.
   PubMed Web of Science ®Google Scholar
• Teng LH, Kumar JR, Leng L, MVRA MS. 2015. Nanoparticle loaded thermosensitive nasal in-situ gels for delivery of loratadine: in-vitro & in-vivo evaluation studies. Alcohol. 1:17–27.
   Google Scholar
• Ukmar T, Gaberšček M, Merzel F, Godec A. 2011. Modus operandi of controlled release from mesoporous matrices: a theoretical perspective. Phys Chem Chem Phys. 13:15311–15317.
   PubMed Web of Science ®Google Scholar
• Ukmar T, Maver U, Planinšek O, Kaučič V, Gaberšček M, Godec A. 2011. Understanding controlled drug release from mesoporous silicates: theory and experiment. J Control Release. 155:409–417.
   PubMed Web of Science ®Google Scholar
• Upadhyay P, Pathak K. 2016. Norfloxacin loaded pH triggered nanoparticulate in situ gel for extraocular bacterial infections: optimization, ocular irritancy and corneal toxicity. Iran J Pharm Res. 15:3–22.
   Web of Science ®Google Scholar
• Valle RF, Sciarra JJ. 2003. Endometriosis: treatment strategies. Ann N Y Acad Sci. 997:229–239.
   PubMed Web of Science ®Google Scholar
• Want MY, Islamuddin M, Chouhan G, Dasgupta AK, Chattopadhyay AP, Afrin F. 2014. A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies. J Colloid Interface Sci. 432:258–269.
   PubMed Web of Science ®Google Scholar
• Wei G, Xu H, Ding PT, Li SM, Zheng JM. 2002. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release. 1883:65–74.
   Google Scholar
• Wei L, McDonald AG. 2015. Thermophysical properties of bacterial poly (3‐hydroxybutyrate): characterized by TMA, DSC, and TMDSC. J Appl Polym Sci. 132:42412.
   Web of Science ®Google Scholar
• Wu C, Qi H, Chen W, Huang C, Su C, Li W, Hou S. 2007. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi. 127:183–191.
   PubMed Web of Science ®Google Scholar
• Yanga YY, Chung TS, Ng NP. 2001. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials. 22:231–241.
   PubMed Web of Science ®Google Scholar
• Zhao SZ, Arguelles LM, Wong JM, Davis MB, Gersh GE, Struthers BJ. 1998. Cost comparisons between nafarelin and leuprolide in the treatment of endometriosis. Clin Ther. 20:592–602.
   PubMed Web of Science ®Google Scholar
• Zhu XH, Wang CH, Tong YW. 2009. In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. J Biomed Mater Res A. 89:411–423.
   PubMed Web of Science ®Google Scholar